全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Clinicopathological Profile of Lung Cancers at an Institute from South India—A Record Based Retrospective Cohort Study

DOI: 10.4236/alc.2020.93005, PP. 41-54

Keywords: Lung Neoplasms, Adenocarcinoma, Squamous Cell Carcinoma, Small Cell Lung Carcinoma

Full-Text   Cite this paper   Add to My Lib

Abstract:

Introduction: Apart from smoking as the known risk factor for lung cancer, recent developments implicate occupational exposure to carcinogens, indoor air pollution and dietary factors as other causative agents. In our study, we have analyzed the clinical and pathological profile of lung cancer patients treated at our center over a period of 8 years. Aim: To find the demographic and clinicopathological profile of lung cancer patients admitted to the oncology unit. Methods: This retrospective record based analysis includes a cohort of 1248 patients diagnosed with lung cancer, at a tertiary cancer care center in Bangalore, South India. This study includes data of patients admitted during the period 2010 to 2018, retrieved from the Hospital’s Electronic Medical Records (EMR). Their demographic profile, clinical correlates, radiological profile and diagnostic details were studied. Benign tumours, malignant pleural disease and sarcomatoid tumors were excluded from this study. Results: Adenocarcinoma (AC) was detected among 70.4% of patients, Squamous cell carcinoma (SCC) among 15.3% and Small cell lung cancer (SCLC) among 14.3% of lung cancer admissions. Male to female ratio was 2.95:1. It was found that the median age of lung cancer patients was 61 years. >60% of lung cancer patients were from the 51 - 70 year age-group. Across the three types of cancers among the patients in Stage 3B to 4 strata, >35% received palliative chemotherapy and >20% received palliative chemotherapy + radiation. Conclusion: In our study, AC is the most common histological subtype (>70%) of lung cancer. The outcome of lung cancer patients can be considerably impacted by addressing risk factors through preventive measures implemented in the community.

References

[1]  Lung Cancer Incidence by Sex, Age-Standardized Rate (World) per 100,000, 2018.
https://canceratlas.cancer.org/the-burden/lung-cancer/
[2]  Noronha, V., Pinninti, R., Patil, V.M., Joshi, A. and Prabhash, K. (2016) Lung Cancer in the Indian Subcontinent. South Asian Journal of Cancer, 5, 95-103.
https://doi.org/10.4103/2278-330X.187571
[3]  Ganguly, S., Biswas, B., Bhattacharjee, S., et al. (2020) Clinicopathological Characteristics and Treatment Outcome in Small Cell Lung Cancer: A Single Institutional Experience from India. Lung India, 37, 134-139.
https://doi.org/10.4103/lungindia.lungindia_370_19
[4]  Behera, D. and Balamugesh, T. (2004) Lung Cancer in India. The Indian Journal of Chest Diseases and Allied Sciences, 46, 269-281.
[5]  Rawat, J., Sindhwani, G., Gaur, D., Dua, R. and Saini, S. (2009) Clinico-Pathological Profile of Lung Cancer in Uttarakhand. Lung India, 26, 74-76.
https://doi.org/10.4103/0970-2113.53229
[6]  Jindal, S.K. and Behera, D. (1990) Clinical Spectrum of Primary Lung Cancer—Review of Chandigarh Experience of 10 Years. Lung India, 8, 94-98.
[7]  Singal, G., Miller, P.G., Agarwala, V., et al. (2019) Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes among Patients with Non-Small Cell Lung Cancer Using a Clinicogenomic Database. JAMA, 321, 1391-1399.
https://doi.org/10.1001/jama.2019.3241
[8]  Malik, P.S., Sharma, M.C., Mohanti, B.K., et al. (2013) Clinico-Pathological Profile of Lung Cancer at AIIMS: A Changing Paradigm in India. Asian Pacific Journal of Cancer Prevention, 14, 489-494.
https://doi.org/10.7314/APJCP.2013.14.1.489
[9]  EGFR-Positive Lung Cancer.
https://lcfamerica.org/lung-cancer-info/types-lung-cancer/egfr-mutation/
[10]  Cruz, C.D., Tanoue, L.T. and Matthay, R.A. (2011) Lung Cancer: Epidemiology, Etiology and Prevention. Clinics in Chest Medicine, 32, 605-644.
https://doi.org/10.1016/j.ccm.2011.09.001
[11]  Dey, A., Biswas, D., Saha, S.K., Kundu, S., Kundu, S. and Sengupta, A. (2012) Comparison Study of Clinicoradiological Profile of Primary Lung Cancer Cases: An Eastern India Experience. Indian Journal of Cancer, 49, 89-95.
https://doi.org/10.4103/0019-509X.98930
[12]  Mural, A.N., Radhakrishnan, V., Ganesan, T.S., et al. (2017) Outcomes in Lung Cancer: 9-Year Experience from a Tertiary Cancer Center in India. Journal of Clinical Oncology, 3, 459-468.
https://doi.org/10.1200/JGO.2016.006676
[13]  Mitsudomi, T. (2014) Molecular Epidemiology of Lung Cancer and Geographic Variations with Special Reference to EGFR Mutations. Translational Lung Cancer Research, 3, 205-211.
[14]  Cheng, T.D., Cramb, S.M., Baade, P.D., et al. (2016) The International Epidemiology of Lung Cancer: Latest Trends, Disparities and Tumor Characteristics. Journal of Thoracic Oncology, 11, 1653-1671.
https://doi.org/10.1016/j.jtho.2016.05.021
[15]  Abudawood, M. (2019) Diabetes and Cancer: A Comprehensive Review. Journal of Research in Medical Sciences, 24, 94.
https://doi.org/10.4103/jrms.JRMS_242_19
[16]  Karlin, N.J., Amin, S.B., Buras, M.R., et al. (2018) Patient Outcomes from Lung Cancer and Diabetes Mellitus: A Matched Case-Control Study. Future Science OA, 4, FSO248.
https://doi.org/10.4155/fsoa-2017-0081
[17]  Werutsky, G., Debiasi, M., Sampaio, F.H., et al. (2016) Updated Analysis of Global Epidemiology of EGFR Mutation in Advanced Non-Small Cell Lung Cancer. Journal of Thoracic Oncology, 11, S184-S185.
https://doi.org/10.1016/j.jtho.2016.08.030
[18]  Izumi, M., Suzumura, T., Ogawa, K., et al. (2019) Differences in Molecular Epidemiology of Lung Cancer among Ethnicities (Asian vs. Caucasian). Journal of Thoracic Disease, 12, No. 7.
[19]  Liu, B., Quan, X., Xu, C., et al. (2019) Lung Cancer in Young Adults Aged 35 Years or Younger: A Full-Scale Analysis and Review. Journal of Cancer, 10, 3553-3559.
https://doi.org/10.7150/jca.27490
[20]  Schwartz, A.G., Prysak, G.M., Bock, C.H. and Cote, M.L. (2007) The Molecular Epidemiology of Lung Cancer. Carcinogenesis, 28, 507-518.
https://doi.org/10.1093/carcin/bgl253
[21]  Singh, N., Aggarwal, A.N. and Behera, D. (2012) Management of Advanced Lung Cancer in Resource-Constrained Settings: A Perspective from India. Expert Review of Anticancer Therapy, 12, 1479-1495.
https://doi.org/10.1586/era.12.119
[22]  Dikshit, R., Gupta, P.C., Ramasundarahettige, C., et al. (2012) Cancer Mortality in India: A Nationally Representative Survey. The Lancet, 379, 1807-1816.
https://doi.org/10.1016/S0140-6736(12)60358-4
[23]  Lin, H.T., Liu, F.C., Wu, C.Y., et al. (2019) Epidemiology and Survival Outcomes of Lung Cancer: A Population-Based Study. BioMed Research International, 2019, Article ID: 8148156.
https://doi.org/10.1155/2019/8148156
[24]  Cardwell, C.R., Mc Menamin, ú., Hughes, C.M. and Murray, L.J. (2015) Statin Use and Survival from Lung Cancer: A Population-Based Cohort Study. Cancer Epidemiology, Biomarkers & Prevention, 24, 833-841.
https://doi.org/10.1158/1055-9965.EPI-15-0052

Full-Text

comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413